In a retrospective review of patient databases, Klinger et al. identified a higher MIB-1 labeling index, higher mitotic figure, and subtotal resection as significant predictors of tumor recurrence involving non-skull base meningioma [22]. Here, MIB1 is linked to skull base meningioma.